Mucociliary differentiation, bronchial epithelial cells, human (Ross 2007)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
MLXIPL
|
ENSG00000009950.11 | MLX interacting protein like |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
MLXIPL | hg19_v2_chr7_-_73038822_73038862, hg19_v2_chr7_-_73038867_73038878 | 0.24 | 2.1e-01 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 2.7 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
0.8 | 2.4 | GO:0019364 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
0.7 | 2.1 | GO:0006535 | cysteine biosynthetic process from serine(GO:0006535) |
0.7 | 2.8 | GO:0003095 | pressure natriuresis(GO:0003095) |
0.6 | 0.6 | GO:1904933 | regulation of cell proliferation in midbrain(GO:1904933) |
0.5 | 1.6 | GO:0045659 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
0.5 | 1.5 | GO:0046136 | positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
0.5 | 1.4 | GO:0042938 | dipeptide transport(GO:0042938) |
0.5 | 2.8 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
0.4 | 1.8 | GO:0006218 | uridine catabolic process(GO:0006218) |
0.4 | 1.7 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
0.4 | 1.3 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.4 | 1.3 | GO:0015728 | mevalonate transport(GO:0015728) behavioral response to nutrient(GO:0051780) |
0.4 | 1.7 | GO:1901662 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.4 | 1.2 | GO:0002325 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) positive regulation of cytolysis in other organism(GO:0051714) |
0.4 | 2.3 | GO:0060744 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.4 | 0.4 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.4 | 1.1 | GO:0042369 | vitamin D catabolic process(GO:0042369) |
0.3 | 1.7 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.3 | 1.0 | GO:0045957 | regulation of complement activation, alternative pathway(GO:0030451) negative regulation of complement activation, alternative pathway(GO:0045957) |
0.3 | 0.9 | GO:2000452 | CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:0035698) regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:2000452) |
0.3 | 6.5 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.3 | 0.9 | GO:1902811 | tongue muscle cell differentiation(GO:0035981) positive regulation of skeletal muscle fiber differentiation(GO:1902811) regulation of tongue muscle cell differentiation(GO:2001035) positive regulation of tongue muscle cell differentiation(GO:2001037) |
0.3 | 0.8 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
0.3 | 2.5 | GO:0015803 | branched-chain amino acid transport(GO:0015803) |
0.3 | 1.3 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.2 | 0.7 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
0.2 | 1.7 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.2 | 1.0 | GO:0086021 | SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) |
0.2 | 0.7 | GO:0070512 | regulation of histone H4-K20 methylation(GO:0070510) positive regulation of histone H4-K20 methylation(GO:0070512) |
0.2 | 0.7 | GO:0006500 | N-terminal protein palmitoylation(GO:0006500) |
0.2 | 0.7 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.2 | 0.7 | GO:0046946 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.2 | 0.9 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
0.2 | 0.9 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.2 | 1.6 | GO:1902722 | positive regulation of prolactin secretion(GO:1902722) |
0.2 | 2.8 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.2 | 0.9 | GO:0046452 | dihydrofolate metabolic process(GO:0046452) |
0.2 | 0.6 | GO:0044209 | AMP salvage(GO:0044209) |
0.2 | 0.6 | GO:1900195 | spindle assembly involved in female meiosis I(GO:0007057) positive regulation of oocyte maturation(GO:1900195) |
0.2 | 1.7 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.2 | 0.6 | GO:0098937 | dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
0.2 | 0.4 | GO:2000309 | positive regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000309) |
0.2 | 1.6 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
0.2 | 0.6 | GO:0019285 | glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
0.2 | 1.0 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.2 | 0.6 | GO:0060157 | urinary bladder development(GO:0060157) |
0.2 | 0.6 | GO:0042138 | meiotic DNA double-strand break processing(GO:0000706) meiotic DNA double-strand break formation(GO:0042138) double-strand break repair involved in meiotic recombination(GO:1990918) |
0.2 | 1.6 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.2 | 0.8 | GO:0010752 | regulation of cGMP-mediated signaling(GO:0010752) |
0.2 | 0.8 | GO:0051037 | regulation of transcription involved in meiotic cell cycle(GO:0051037) |
0.2 | 0.6 | GO:0008355 | olfactory learning(GO:0008355) |
0.2 | 0.8 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
0.2 | 0.5 | GO:1902910 | regulation of monophenol monooxygenase activity(GO:0032771) positive regulation of monophenol monooxygenase activity(GO:0032773) negative regulation of catagen(GO:0051796) regulation of hair cycle by canonical Wnt signaling pathway(GO:0060901) positive regulation of melanosome transport(GO:1902910) |
0.2 | 5.2 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.2 | 0.2 | GO:0009719 | response to endogenous stimulus(GO:0009719) |
0.2 | 1.1 | GO:0002760 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
0.2 | 0.2 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.2 | 1.6 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.2 | 1.9 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.2 | 2.2 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.2 | 0.5 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.2 | 0.8 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.2 | 0.8 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
0.2 | 0.5 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.2 | 1.0 | GO:0030421 | defecation(GO:0030421) |
0.2 | 0.5 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
0.2 | 0.2 | GO:0036466 | synaptic vesicle recycling via endosome(GO:0036466) |
0.2 | 0.6 | GO:0001189 | RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
0.2 | 0.8 | GO:0044571 | [2Fe-2S] cluster assembly(GO:0044571) |
0.2 | 0.5 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.2 | 0.8 | GO:0001828 | inner cell mass cell fate commitment(GO:0001827) inner cell mass cellular morphogenesis(GO:0001828) |
0.2 | 0.5 | GO:0014806 | negative regulation of muscle hyperplasia(GO:0014740) smooth muscle hyperplasia(GO:0014806) |
0.2 | 0.8 | GO:0009440 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
0.2 | 1.8 | GO:0035986 | senescence-associated heterochromatin focus assembly(GO:0035986) |
0.2 | 0.6 | GO:1990868 | response to chemokine(GO:1990868) cellular response to chemokine(GO:1990869) |
0.2 | 0.8 | GO:1904674 | positive regulation of somatic stem cell population maintenance(GO:1904674) |
0.2 | 0.5 | GO:0002384 | hepatic immune response(GO:0002384) |
0.1 | 0.9 | GO:0052565 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
0.1 | 0.3 | GO:0060042 | retina morphogenesis in camera-type eye(GO:0060042) |
0.1 | 0.1 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.1 | 0.9 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
0.1 | 0.7 | GO:0033490 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
0.1 | 1.3 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
0.1 | 0.9 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
0.1 | 0.7 | GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.1 | 0.6 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.1 | 1.8 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.1 | 0.6 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
0.1 | 0.6 | GO:0006238 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
0.1 | 0.4 | GO:0045210 | negative regulation of dendritic cell cytokine production(GO:0002731) FasL biosynthetic process(GO:0045210) |
0.1 | 1.0 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.1 | 0.6 | GO:2001151 | regulation of renal water transport(GO:2001151) positive regulation of renal water transport(GO:2001153) |
0.1 | 1.1 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.1 | 0.8 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.1 | 0.5 | GO:0061107 | seminal vesicle development(GO:0061107) |
0.1 | 0.5 | GO:1902499 | positive regulation of protein autoubiquitination(GO:1902499) |
0.1 | 0.3 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
0.1 | 0.1 | GO:0090427 | activation of meiosis(GO:0090427) |
0.1 | 0.8 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 0.4 | GO:0045062 | extrathymic T cell selection(GO:0045062) |
0.1 | 0.3 | GO:0036146 | cellular response to mycotoxin(GO:0036146) |
0.1 | 0.7 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
0.1 | 0.4 | GO:1901994 | meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) negative regulation of meiotic cell cycle phase transition(GO:1901994) |
0.1 | 0.4 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
0.1 | 0.6 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.1 | 0.5 | GO:0070352 | positive regulation of white fat cell proliferation(GO:0070352) |
0.1 | 0.6 | GO:0060611 | mammary gland fat development(GO:0060611) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) positive regulation of microglial cell migration(GO:1904141) |
0.1 | 0.4 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.1 | 0.5 | GO:0035425 | autocrine signaling(GO:0035425) |
0.1 | 0.4 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
0.1 | 0.4 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.1 | 0.8 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.1 | 0.6 | GO:0030047 | actin modification(GO:0030047) |
0.1 | 0.5 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
0.1 | 0.2 | GO:0034241 | macrophage fusion(GO:0034238) regulation of macrophage fusion(GO:0034239) positive regulation of macrophage fusion(GO:0034241) |
0.1 | 0.4 | GO:0018008 | N-terminal peptidyl-glycine N-myristoylation(GO:0018008) |
0.1 | 0.7 | GO:0042816 | vitamin B6 metabolic process(GO:0042816) |
0.1 | 0.8 | GO:0021840 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
0.1 | 0.7 | GO:0070458 | cellular detoxification of nitrogen compound(GO:0070458) |
0.1 | 4.0 | GO:1904659 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
0.1 | 0.9 | GO:0007144 | female meiosis I(GO:0007144) |
0.1 | 0.1 | GO:0072254 | metanephric mesangial cell differentiation(GO:0072209) metanephric glomerular mesangial cell differentiation(GO:0072254) |
0.1 | 0.3 | GO:0070638 | nicotinamide riboside catabolic process(GO:0006738) nicotinamide riboside metabolic process(GO:0046495) pyridine nucleoside metabolic process(GO:0070637) pyridine nucleoside catabolic process(GO:0070638) |
0.1 | 1.7 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.1 | 0.2 | GO:0030261 | chromosome condensation(GO:0030261) |
0.1 | 0.3 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.1 | 0.7 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.1 | 0.4 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.1 | 0.4 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
0.1 | 0.3 | GO:0097359 | UDP-glucosylation(GO:0097359) |
0.1 | 0.3 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.1 | 0.8 | GO:1900625 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.1 | 0.2 | GO:0045994 | positive regulation of translational initiation by iron(GO:0045994) |
0.1 | 0.3 | GO:1905166 | negative regulation of protein catabolic process in the vacuole(GO:1904351) negative regulation of lysosomal protein catabolic process(GO:1905166) |
0.1 | 1.3 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) |
0.1 | 0.3 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.1 | 0.2 | GO:1901253 | negative regulation of intracellular transport of viral material(GO:1901253) |
0.1 | 0.8 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.1 | 0.3 | GO:1900073 | regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
0.1 | 0.3 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
0.1 | 0.2 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
0.1 | 1.2 | GO:0019532 | oxalate transport(GO:0019532) |
0.1 | 0.5 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.1 | 0.7 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.1 | 0.2 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.1 | 0.3 | GO:0019056 | modulation by virus of host transcription(GO:0019056) positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
0.1 | 0.5 | GO:0046440 | L-lysine catabolic process to acetyl-CoA(GO:0019474) L-lysine catabolic process(GO:0019477) L-lysine metabolic process(GO:0046440) |
0.1 | 0.3 | GO:0071789 | spindle pole body duplication(GO:0030474) spindle pole body organization(GO:0051300) spindle pole body localization(GO:0070631) establishment of spindle pole body localization(GO:0070632) spindle pole body localization to nuclear envelope(GO:0071789) establishment of spindle pole body localization to nuclear envelope(GO:0071790) |
0.1 | 0.3 | GO:1904717 | excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
0.1 | 0.4 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) positive regulation of lysosomal protein catabolic process(GO:1905167) |
0.1 | 0.1 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.1 | 0.1 | GO:1903378 | positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
0.1 | 1.6 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.1 | 0.9 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.1 | 0.6 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.1 | 0.6 | GO:0089712 | L-aspartate transport(GO:0070778) L-aspartate transmembrane transport(GO:0089712) |
0.1 | 0.2 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.1 | 0.3 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
0.1 | 0.3 | GO:1903413 | cellular response to bile acid(GO:1903413) |
0.1 | 0.3 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
0.1 | 0.5 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.1 | 0.8 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.1 | 0.2 | GO:0002461 | tolerance induction dependent upon immune response(GO:0002461) |
0.1 | 0.3 | GO:0060823 | canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060823) |
0.1 | 0.3 | GO:0021913 | glandular epithelial cell maturation(GO:0002071) regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) type B pancreatic cell maturation(GO:0072560) |
0.1 | 0.4 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
0.1 | 0.4 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
0.1 | 0.4 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.1 | 0.2 | GO:0036378 | calcitriol biosynthetic process from calciol(GO:0036378) |
0.1 | 2.0 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.1 | 0.2 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.1 | 0.3 | GO:0071393 | cellular response to progesterone stimulus(GO:0071393) |
0.1 | 0.3 | GO:0071500 | negative regulation of CREB transcription factor activity(GO:0032792) cellular response to nitrosative stress(GO:0071500) |
0.1 | 3.4 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.1 | 0.3 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.1 | 0.2 | GO:0090312 | positive regulation of protein deacetylation(GO:0090312) |
0.1 | 0.3 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.1 | 0.6 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.1 | 0.4 | GO:0010273 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.1 | 1.0 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.1 | 0.5 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 0.6 | GO:0035799 | ureter maturation(GO:0035799) |
0.1 | 0.8 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.1 | 0.6 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.1 | 0.4 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.1 | 0.3 | GO:0042109 | lymphotoxin A production(GO:0032641) lymphotoxin A biosynthetic process(GO:0042109) |
0.1 | 0.2 | GO:0072428 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
0.1 | 0.2 | GO:0018057 | peptidyl-lysine oxidation(GO:0018057) |
0.1 | 0.5 | GO:0032252 | secretory granule localization(GO:0032252) |
0.1 | 0.8 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.1 | 0.1 | GO:0050666 | regulation of sulfur amino acid metabolic process(GO:0031335) regulation of homocysteine metabolic process(GO:0050666) |
0.1 | 0.2 | GO:0018201 | N-terminal protein amino acid methylation(GO:0006480) N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) peptidyl-glycine modification(GO:0018201) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
0.1 | 0.2 | GO:1904180 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.1 | 0.2 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
0.1 | 0.4 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.1 | 0.3 | GO:0035625 | negative regulation of epinephrine secretion(GO:0032811) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
0.1 | 0.4 | GO:1990834 | response to odorant(GO:1990834) |
0.1 | 0.1 | GO:0009441 | glycolate metabolic process(GO:0009441) |
0.1 | 0.7 | GO:0002158 | osteoclast proliferation(GO:0002158) |
0.1 | 0.2 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.1 | 0.4 | GO:0007000 | nucleolus organization(GO:0007000) |
0.1 | 1.0 | GO:0052696 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.1 | 0.7 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
0.1 | 0.8 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.1 | 0.6 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.1 | 0.2 | GO:0060976 | coronary vasculature development(GO:0060976) |
0.1 | 0.5 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
0.1 | 0.4 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.1 | 0.1 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.1 | 0.1 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.1 | 0.9 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.1 | 0.2 | GO:0035552 | oxidative single-stranded DNA demethylation(GO:0035552) |
0.1 | 0.2 | GO:0072108 | positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0072108) |
0.1 | 0.2 | GO:0001978 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.1 | 0.3 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.1 | 0.2 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.1 | 1.2 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.1 | 0.3 | GO:0050883 | negative regulation of sodium:proton antiporter activity(GO:0032416) musculoskeletal movement, spinal reflex action(GO:0050883) |
0.1 | 0.5 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
0.1 | 0.4 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
0.1 | 0.5 | GO:0070508 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.1 | 0.2 | GO:0035565 | regulation of pronephros size(GO:0035565) renal glucose absorption(GO:0035623) |
0.1 | 0.3 | GO:0010767 | regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage(GO:0010767) development involved in symbiotic interaction(GO:0044111) |
0.1 | 0.9 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.1 | 0.4 | GO:0071105 | response to interleukin-11(GO:0071105) |
0.1 | 0.9 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.1 | 1.0 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.1 | 0.4 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.1 | 0.2 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
0.1 | 1.2 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.1 | 0.2 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.1 | 0.3 | GO:0032431 | activation of phospholipase A2 activity(GO:0032431) |
0.1 | 0.6 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.1 | 0.1 | GO:0060956 | cardiac endothelial cell differentiation(GO:0003348) endocardial cell differentiation(GO:0060956) |
0.1 | 0.2 | GO:0042851 | L-alanine metabolic process(GO:0042851) L-alanine catabolic process(GO:0042853) |
0.1 | 0.3 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.1 | 0.3 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.1 | 0.3 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
0.1 | 0.1 | GO:2000619 | negative regulation of histone H4-K16 acetylation(GO:2000619) |
0.1 | 0.1 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.1 | 0.4 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.1 | 0.2 | GO:0097187 | dentinogenesis(GO:0097187) |
0.1 | 0.2 | GO:0051106 | positive regulation of DNA ligation(GO:0051106) |
0.1 | 0.6 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
0.1 | 0.4 | GO:0035709 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
0.1 | 0.3 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 0.2 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
0.1 | 0.3 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.1 | 0.3 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) |
0.1 | 0.2 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
0.1 | 0.2 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
0.1 | 0.2 | GO:0046066 | dGDP metabolic process(GO:0046066) |
0.1 | 0.1 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.1 | 0.3 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.1 | 1.1 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.1 | 0.4 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.1 | 0.1 | GO:0033861 | negative regulation of NAD(P)H oxidase activity(GO:0033861) |
0.1 | 0.6 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.1 | 0.6 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.1 | 0.3 | GO:0015862 | uridine transport(GO:0015862) |
0.1 | 0.2 | GO:0098502 | DNA dephosphorylation(GO:0098502) |
0.1 | 0.2 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
0.1 | 0.3 | GO:1903435 | positive regulation of constitutive secretory pathway(GO:1903435) |
0.1 | 0.3 | GO:0061364 | apoptotic process involved in luteolysis(GO:0061364) |
0.1 | 0.2 | GO:0003335 | corneocyte development(GO:0003335) |
0.1 | 0.9 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.1 | 0.6 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.1 | 0.2 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.1 | 0.2 | GO:0006097 | glyoxylate cycle(GO:0006097) |
0.1 | 0.4 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.1 | 0.2 | GO:0032679 | TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) |
0.1 | 0.2 | GO:0071418 | cellular response to amine stimulus(GO:0071418) |
0.1 | 0.2 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.1 | 0.4 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.1 | 0.5 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.1 | 0.3 | GO:1904751 | positive regulation of telomeric DNA binding(GO:1904744) positive regulation of protein localization to nucleolus(GO:1904751) |
0.1 | 0.3 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.1 | 0.2 | GO:2000542 | negative regulation of gastrulation(GO:2000542) |
0.1 | 0.5 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
0.1 | 0.8 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
0.1 | 0.5 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.1 | 1.1 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
0.1 | 0.4 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.1 | 0.3 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.1 | 0.4 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
0.1 | 0.6 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.1 | 1.1 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.1 | 0.2 | GO:0043323 | regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
0.1 | 0.2 | GO:0002086 | diaphragm contraction(GO:0002086) |
0.1 | 0.2 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
0.1 | 0.2 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
0.1 | 1.0 | GO:0002544 | chronic inflammatory response(GO:0002544) |
0.1 | 0.2 | GO:0042137 | sequestering of neurotransmitter(GO:0042137) |
0.1 | 1.0 | GO:0006751 | glutathione catabolic process(GO:0006751) |
0.1 | 0.1 | GO:1901859 | negative regulation of mitochondrial DNA replication(GO:0090298) negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
0.1 | 0.1 | GO:0002125 | maternal aggressive behavior(GO:0002125) |
0.1 | 1.6 | GO:0032332 | positive regulation of chondrocyte differentiation(GO:0032332) |
0.1 | 0.2 | GO:1904730 | negative regulation of intestinal phytosterol absorption(GO:0010949) negative regulation of intestinal cholesterol absorption(GO:0045796) intestinal phytosterol absorption(GO:0060752) negative regulation of intestinal lipid absorption(GO:1904730) |
0.1 | 1.6 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 0.1 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.0 | 1.3 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.0 | 0.2 | GO:0044108 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) cellular alcohol metabolic process(GO:0044107) cellular alcohol biosynthetic process(GO:0044108) |
0.0 | 0.2 | GO:1903438 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
0.0 | 0.4 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
0.0 | 0.3 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.0 | 0.1 | GO:0070305 | response to cGMP(GO:0070305) |
0.0 | 0.7 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.0 | 0.2 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.0 | 0.4 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.0 | 0.2 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
0.0 | 0.2 | GO:0071934 | thiamine transmembrane transport(GO:0071934) |
0.0 | 0.1 | GO:0007518 | myoblast fate determination(GO:0007518) |
0.0 | 3.3 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.0 | 0.2 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) |
0.0 | 0.0 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.0 | 0.3 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.0 | 0.8 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.0 | 0.5 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.0 | 0.1 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.0 | 0.1 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
0.0 | 2.0 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.0 | 0.1 | GO:0021644 | vagus nerve morphogenesis(GO:0021644) postganglionic parasympathetic fiber development(GO:0021784) chemorepulsion of branchiomotor axon(GO:0021793) |
0.0 | 0.1 | GO:0070370 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
0.0 | 0.1 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.0 | 0.7 | GO:0051639 | actin filament network formation(GO:0051639) |
0.0 | 0.2 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.0 | 0.5 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.0 | 0.4 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) |
0.0 | 0.3 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.0 | 0.6 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
0.0 | 0.2 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.0 | 0.2 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
0.0 | 0.4 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.0 | 0.2 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.0 | 0.1 | GO:0002728 | negative regulation of natural killer cell cytokine production(GO:0002728) |
0.0 | 0.5 | GO:0061036 | positive regulation of cartilage development(GO:0061036) |
0.0 | 0.3 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.0 | 0.1 | GO:0001694 | histamine biosynthetic process(GO:0001694) |
0.0 | 0.1 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
0.0 | 0.2 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.0 | 0.1 | GO:0071301 | transcription factor catabolic process(GO:0036369) cellular response to vitamin B1(GO:0071301) response to formaldehyde(GO:1904404) |
0.0 | 0.2 | GO:0002316 | follicular B cell differentiation(GO:0002316) |
0.0 | 0.1 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
0.0 | 0.3 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.0 | 0.5 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.0 | 0.2 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.0 | 0.3 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
0.0 | 0.5 | GO:0006828 | manganese ion transport(GO:0006828) |
0.0 | 0.0 | GO:0099543 | retrograde trans-synaptic signaling by soluble gas(GO:0098923) trans-synaptic signaling by soluble gas(GO:0099543) |
0.0 | 0.1 | GO:0002159 | desmosome assembly(GO:0002159) |
0.0 | 0.1 | GO:2000330 | interleukin-23-mediated signaling pathway(GO:0038155) positive regulation of T-helper 17 cell lineage commitment(GO:2000330) |
0.0 | 1.3 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.0 | 0.4 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.0 | 0.2 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) branch elongation involved in mammary gland duct branching(GO:0060751) |
0.0 | 0.2 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.0 | 0.7 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.0 | 0.4 | GO:0002024 | diet induced thermogenesis(GO:0002024) |
0.0 | 0.1 | GO:0060513 | prostatic bud formation(GO:0060513) |
0.0 | 0.1 | GO:0015993 | molecular hydrogen transport(GO:0015993) |
0.0 | 0.1 | GO:0060722 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
0.0 | 0.4 | GO:2000582 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
0.0 | 0.1 | GO:0019242 | methylglyoxal biosynthetic process(GO:0019242) |
0.0 | 0.2 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.0 | 0.1 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.0 | 0.1 | GO:0033341 | regulation of collagen binding(GO:0033341) |
0.0 | 0.2 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.0 | 1.4 | GO:0050716 | positive regulation of interleukin-1 secretion(GO:0050716) |
0.0 | 0.4 | GO:0060117 | auditory receptor cell development(GO:0060117) |
0.0 | 0.2 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.0 | 0.1 | GO:0015966 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
0.0 | 0.2 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.0 | 0.3 | GO:0003374 | dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) |
0.0 | 0.4 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.0 | 0.5 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
0.0 | 0.0 | GO:1901624 | negative regulation of lymphocyte chemotaxis(GO:1901624) negative regulation of natural killer cell chemotaxis(GO:2000502) |
0.0 | 0.9 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
0.0 | 0.5 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
0.0 | 0.2 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.0 | 0.2 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.0 | 0.6 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.0 | 0.3 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.0 | 0.1 | GO:0035281 | pre-miRNA export from nucleus(GO:0035281) |
0.0 | 0.3 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.0 | 0.1 | GO:1905123 | regulation of glucosylceramidase activity(GO:1905123) |
0.0 | 0.1 | GO:0036071 | N-glycan fucosylation(GO:0036071) |
0.0 | 0.3 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.0 | 0.1 | GO:0003383 | apical constriction(GO:0003383) |
0.0 | 0.2 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.0 | 0.2 | GO:0019064 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.0 | 0.8 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.0 | 0.1 | GO:0050428 | purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
0.0 | 0.1 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
0.0 | 0.5 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.0 | 0.0 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.0 | 0.5 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.0 | 0.4 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.0 | 0.5 | GO:0002230 | positive regulation of defense response to virus by host(GO:0002230) |
0.0 | 0.2 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.0 | 0.1 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
0.0 | 0.4 | GO:0036155 | acylglycerol acyl-chain remodeling(GO:0036155) |
0.0 | 0.1 | GO:0036292 | DNA rewinding(GO:0036292) |
0.0 | 0.4 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.0 | 0.5 | GO:0007172 | signal complex assembly(GO:0007172) |
0.0 | 0.3 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.0 | 0.4 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.0 | 0.1 | GO:0042116 | macrophage activation(GO:0042116) |
0.0 | 0.7 | GO:0033198 | response to ATP(GO:0033198) |
0.0 | 0.1 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) |
0.0 | 0.4 | GO:1904896 | ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
0.0 | 0.2 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.0 | 0.3 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.0 | 1.9 | GO:1901998 | toxin transport(GO:1901998) |
0.0 | 0.2 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.0 | 0.5 | GO:0098703 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
0.0 | 0.1 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.0 | 0.4 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.0 | 0.0 | GO:0070922 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) siRNA loading onto RISC involved in RNA interference(GO:0035087) small RNA loading onto RISC(GO:0070922) |
0.0 | 0.1 | GO:0016115 | terpenoid catabolic process(GO:0016115) |
0.0 | 0.3 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
0.0 | 0.2 | GO:0099540 | synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
0.0 | 0.2 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.0 | 0.2 | GO:0035878 | nail development(GO:0035878) |
0.0 | 0.1 | GO:0010982 | negative regulation of triglyceride catabolic process(GO:0010897) regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.0 | 0.1 | GO:0035674 | tricarboxylic acid transmembrane transport(GO:0035674) |
0.0 | 0.4 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.0 | 0.1 | GO:0009750 | response to fructose(GO:0009750) |
0.0 | 0.1 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.0 | 0.6 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.0 | 0.2 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.0 | 0.2 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.0 | 0.0 | GO:0044117 | growth of symbiont in host(GO:0044117) |
0.0 | 0.3 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.0 | 0.1 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.0 | 0.3 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.0 | 0.4 | GO:0045061 | thymic T cell selection(GO:0045061) |
0.0 | 0.1 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.0 | 0.2 | GO:1903575 | cornified envelope assembly(GO:1903575) |
0.0 | 0.1 | GO:0003257 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003257) positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
0.0 | 0.9 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.0 | 0.7 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.0 | 0.3 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
0.0 | 0.4 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.0 | 0.1 | GO:0070781 | response to biotin(GO:0070781) |
0.0 | 0.1 | GO:0061386 | closure of optic fissure(GO:0061386) |
0.0 | 0.4 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.0 | 0.1 | GO:1903298 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
0.0 | 0.3 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.0 | 0.2 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
0.0 | 0.2 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.0 | 0.3 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.0 | 0.1 | GO:0019627 | urea cycle(GO:0000050) urea metabolic process(GO:0019627) |
0.0 | 0.2 | GO:0034465 | response to carbon monoxide(GO:0034465) smooth muscle contraction involved in micturition(GO:0060083) |
0.0 | 0.2 | GO:0090070 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
0.0 | 0.1 | GO:1901382 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.0 | 0.2 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.0 | 0.3 | GO:0098602 | single organism cell adhesion(GO:0098602) |
0.0 | 0.4 | GO:0045954 | positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.0 | 0.1 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.0 | 0.3 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.0 | 0.1 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.0 | 0.1 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.0 | 0.1 | GO:0061050 | regulation of cell growth involved in cardiac muscle cell development(GO:0061050) |
0.0 | 0.8 | GO:0097421 | liver regeneration(GO:0097421) |
0.0 | 0.5 | GO:0051601 | exocyst localization(GO:0051601) |
0.0 | 0.1 | GO:2001140 | regulation of phospholipid transport(GO:2001138) positive regulation of phospholipid transport(GO:2001140) |
0.0 | 0.2 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.0 | 0.4 | GO:0050832 | defense response to fungus(GO:0050832) |
0.0 | 0.1 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.0 | 0.2 | GO:0060056 | mammary gland involution(GO:0060056) |
0.0 | 0.2 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.0 | 1.4 | GO:0006739 | NADP metabolic process(GO:0006739) |
0.0 | 0.0 | GO:0090116 | C-5 methylation of cytosine(GO:0090116) |
0.0 | 0.2 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.0 | 1.2 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.0 | 4.2 | GO:0038096 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
0.0 | 0.2 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) |
0.0 | 2.9 | GO:0006939 | smooth muscle contraction(GO:0006939) |
0.0 | 0.3 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
0.0 | 0.6 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.0 | 0.1 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) mitochondrial tRNA 3'-end processing(GO:1990180) |
0.0 | 0.1 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.0 | 0.2 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.0 | 0.1 | GO:0036023 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.0 | 0.0 | GO:1903758 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
0.0 | 0.1 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.0 | 0.2 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.0 | 0.2 | GO:1903311 | regulation of mRNA metabolic process(GO:1903311) |
0.0 | 0.1 | GO:0018377 | protein myristoylation(GO:0018377) |
0.0 | 0.1 | GO:0036510 | trimming of terminal mannose on C branch(GO:0036510) |
0.0 | 0.4 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.0 | 0.1 | GO:0090650 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
0.0 | 0.4 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.0 | 1.5 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.0 | 0.2 | GO:0007498 | mesoderm development(GO:0007498) |
0.0 | 0.1 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.0 | 0.1 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.0 | 0.5 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.0 | 0.2 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.0 | 0.1 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.0 | 0.3 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.0 | 0.2 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.0 | 1.1 | GO:0006636 | unsaturated fatty acid biosynthetic process(GO:0006636) |
0.0 | 0.5 | GO:0022038 | corpus callosum development(GO:0022038) |
0.0 | 0.3 | GO:0090520 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
0.0 | 0.0 | GO:0035668 | TRAM-dependent toll-like receptor signaling pathway(GO:0035668) TRAM-dependent toll-like receptor 4 signaling pathway(GO:0035669) |
0.0 | 0.1 | GO:1904806 | regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
0.0 | 0.2 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.0 | 0.3 | GO:0007565 | female pregnancy(GO:0007565) |
0.0 | 0.4 | GO:0090305 | nucleic acid phosphodiester bond hydrolysis(GO:0090305) |
0.0 | 0.1 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.0 | 0.1 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
0.0 | 0.7 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.0 | 0.1 | GO:0038170 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
0.0 | 0.4 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.0 | 0.5 | GO:0048757 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.0 | 0.1 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.0 | 0.4 | GO:0000338 | protein deneddylation(GO:0000338) |
0.0 | 0.1 | GO:1903826 | arginine transmembrane transport(GO:1903826) |
0.0 | 0.4 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.0 | 0.9 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.0 | 0.2 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.0 | 0.1 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.0 | 0.2 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.0 | 0.7 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.0 | 0.2 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
0.0 | 1.5 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.0 | 0.3 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.0 | 0.1 | GO:0014002 | astrocyte development(GO:0014002) |
0.0 | 0.7 | GO:0060325 | face morphogenesis(GO:0060325) |
0.0 | 0.1 | GO:0006433 | glutamyl-tRNA aminoacylation(GO:0006424) prolyl-tRNA aminoacylation(GO:0006433) |
0.0 | 0.3 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
0.0 | 0.3 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.0 | 0.1 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
0.0 | 0.2 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.0 | 0.6 | GO:1901687 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
0.0 | 0.5 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.0 | 0.5 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.0 | 0.3 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.0 | 0.1 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.0 | 0.4 | GO:0001502 | cartilage condensation(GO:0001502) |
0.0 | 0.1 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
0.0 | 0.3 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
0.0 | 0.0 | GO:0060992 | response to fungicide(GO:0060992) |
0.0 | 0.1 | GO:0008218 | bioluminescence(GO:0008218) |
0.0 | 0.3 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.0 | 0.1 | GO:1990167 | protein K29-linked deubiquitination(GO:0035523) protein K27-linked deubiquitination(GO:1990167) protein K33-linked deubiquitination(GO:1990168) |
0.0 | 0.2 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.0 | 0.1 | GO:0006850 | mitochondrial pyruvate transport(GO:0006850) mitochondrial pyruvate transmembrane transport(GO:1902361) |
0.0 | 0.8 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.0 | 0.1 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
0.0 | 0.3 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.0 | 0.2 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
0.0 | 1.3 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.0 | 0.0 | GO:1903721 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
0.0 | 0.2 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.0 | 0.1 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.0 | 0.2 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.0 | 0.1 | GO:0097354 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.0 | 0.1 | GO:0032490 | detection of molecule of bacterial origin(GO:0032490) |
0.0 | 0.1 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
0.0 | 0.1 | GO:0044245 | polysaccharide digestion(GO:0044245) |
0.0 | 0.2 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.0 | 0.2 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.0 | 0.2 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.0 | 0.0 | GO:0002251 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
0.0 | 0.1 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.0 | 0.1 | GO:0052027 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
0.0 | 0.3 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.0 | 2.3 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.0 | 0.1 | GO:0051480 | regulation of cytosolic calcium ion concentration(GO:0051480) |
0.0 | 0.2 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.0 | 0.1 | GO:0015824 | proline transport(GO:0015824) |
0.0 | 0.1 | GO:0055014 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
0.0 | 0.5 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.0 | 0.1 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.0 | 1.0 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 0.0 | GO:0071623 | negative regulation of granulocyte chemotaxis(GO:0071623) negative regulation of neutrophil chemotaxis(GO:0090024) negative regulation of neutrophil migration(GO:1902623) |
0.0 | 0.1 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.0 | 0.1 | GO:0046707 | IDP metabolic process(GO:0046707) IDP catabolic process(GO:0046709) |
0.0 | 0.0 | GO:0060295 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.0 | 0.2 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.0 | 0.1 | GO:0042330 | chemotaxis(GO:0006935) taxis(GO:0042330) |
0.0 | 0.1 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.0 | 0.1 | GO:0060283 | negative regulation of oocyte development(GO:0060283) regulation of oocyte maturation(GO:1900193) negative regulation of oocyte maturation(GO:1900194) |
0.0 | 0.0 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.0 | 0.1 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.0 | 0.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 1.0 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.0 | 0.2 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.0 | 0.2 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.0 | 0.2 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.0 | 0.1 | GO:0009446 | putrescine biosynthetic process(GO:0009446) putrescine biosynthetic process from ornithine(GO:0033387) |
0.0 | 0.1 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.0 | 0.3 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.0 | 0.3 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.0 | 0.2 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.0 | 0.1 | GO:0006848 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.0 | 0.4 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.0 | 0.7 | GO:0007566 | embryo implantation(GO:0007566) |
0.0 | 0.1 | GO:0007512 | adult heart development(GO:0007512) |
0.0 | 0.2 | GO:0048070 | regulation of developmental pigmentation(GO:0048070) |
0.0 | 0.1 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.0 | 0.1 | GO:0030216 | keratinocyte differentiation(GO:0030216) |
0.0 | 0.1 | GO:2001034 | positive regulation of double-strand break repair via nonhomologous end joining(GO:2001034) |
0.0 | 0.5 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.0 | 0.2 | GO:0034310 | primary alcohol catabolic process(GO:0034310) |
0.0 | 0.2 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.0 | 0.2 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.0 | 0.1 | GO:0051182 | coenzyme transport(GO:0051182) |
0.0 | 0.0 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.0 | 0.6 | GO:0019835 | cytolysis(GO:0019835) |
0.0 | 0.1 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.0 | 0.3 | GO:0045124 | regulation of bone resorption(GO:0045124) |
0.0 | 0.1 | GO:0042414 | epinephrine metabolic process(GO:0042414) epinephrine biosynthetic process(GO:0042418) |
0.0 | 0.1 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.0 | 0.1 | GO:0003418 | growth plate cartilage chondrocyte differentiation(GO:0003418) |
0.0 | 0.6 | GO:0061045 | negative regulation of wound healing(GO:0061045) |
0.0 | 0.1 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
0.0 | 0.0 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) |
0.0 | 0.1 | GO:0021854 | hypothalamus development(GO:0021854) |
0.0 | 0.2 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.0 | 0.3 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.0 | 0.1 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.0 | 0.2 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.0 | 0.3 | GO:0071498 | cellular response to fluid shear stress(GO:0071498) |
0.0 | 0.2 | GO:0048169 | regulation of long-term neuronal synaptic plasticity(GO:0048169) |
0.0 | 0.1 | GO:0045471 | response to ethanol(GO:0045471) |
0.0 | 0.1 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.0 | 0.1 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.0 | 0.1 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.0 | 0.3 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) |
0.0 | 0.2 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
0.0 | 0.2 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.0 | 0.2 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.0 | 0.3 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.3 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.0 | 0.2 | GO:0006265 | DNA topological change(GO:0006265) |
0.0 | 0.2 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.0 | 0.1 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.0 | 0.1 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.0 | 0.2 | GO:0072574 | hepatocyte proliferation(GO:0072574) epithelial cell proliferation involved in liver morphogenesis(GO:0072575) liver morphogenesis(GO:0072576) |
0.0 | 0.2 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.0 | 0.1 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.0 | 0.1 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.0 | 0.3 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.0 | 0.7 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
0.0 | 0.1 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.0 | 0.1 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.0 | 0.1 | GO:0031627 | telomeric loop formation(GO:0031627) |
0.0 | 0.1 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.0 | 0.2 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.0 | 0.0 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.0 | 0.0 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.0 | 0.1 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.0 | 0.2 | GO:0014003 | oligodendrocyte development(GO:0014003) |
0.0 | 0.1 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.0 | 0.2 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
0.0 | 0.1 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.0 | 0.4 | GO:0032570 | response to progesterone(GO:0032570) |
0.0 | 0.1 | GO:0007129 | synapsis(GO:0007129) |
0.0 | 0.1 | GO:0014029 | neural crest formation(GO:0014029) |
0.0 | 0.0 | GO:0006423 | cysteinyl-tRNA aminoacylation(GO:0006423) |
0.0 | 0.1 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.0 | 0.3 | GO:0030166 | proteoglycan biosynthetic process(GO:0030166) |
0.0 | 0.1 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.0 | 0.1 | GO:0015747 | urate transport(GO:0015747) |
0.0 | 0.1 | GO:0006540 | glutamate decarboxylation to succinate(GO:0006540) |
0.0 | 0.2 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.0 | 0.3 | GO:0070228 | regulation of lymphocyte apoptotic process(GO:0070228) |
0.0 | 0.0 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
0.0 | 0.1 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.0 | 0.2 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.0 | 0.1 | GO:0032218 | riboflavin transport(GO:0032218) |
0.0 | 0.0 | GO:0050691 | regulation of defense response to virus by host(GO:0050691) |
0.0 | 0.4 | GO:0001960 | negative regulation of cytokine-mediated signaling pathway(GO:0001960) |
0.0 | 0.0 | GO:0002534 | cytokine production involved in inflammatory response(GO:0002534) |
0.0 | 0.0 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
0.0 | 0.0 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
0.0 | 0.3 | GO:0006953 | acute-phase response(GO:0006953) |
0.0 | 0.1 | GO:0000012 | single strand break repair(GO:0000012) |
0.0 | 0.1 | GO:0000066 | mitochondrial ornithine transport(GO:0000066) |
0.0 | 0.2 | GO:2000179 | positive regulation of neural precursor cell proliferation(GO:2000179) |
0.0 | 0.1 | GO:0048704 | embryonic skeletal system morphogenesis(GO:0048704) |
0.0 | 0.1 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.0 | 0.1 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.0 | 0.2 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.0 | 0.1 | GO:0048290 | isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) positive regulation of isotype switching to IgA isotypes(GO:0048298) |
0.0 | 0.1 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
0.0 | 0.1 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
0.0 | 0.3 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.0 | 0.2 | GO:0010762 | regulation of fibroblast migration(GO:0010762) |
0.0 | 0.1 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
0.0 | 0.2 | GO:0001836 | release of cytochrome c from mitochondria(GO:0001836) |
0.0 | 0.2 | GO:1903206 | negative regulation of hydrogen peroxide-induced cell death(GO:1903206) |
0.0 | 0.1 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
0.0 | 0.2 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.0 | 0.2 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
0.0 | 0.1 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.0 | 0.1 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.0 | 0.0 | GO:0030029 | actin filament-based process(GO:0030029) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 2.0 | GO:1990015 | mesaxon(GO:0097453) ensheathing process(GO:1990015) |
0.6 | 4.9 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.5 | 0.5 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.3 | 1.0 | GO:0036387 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
0.3 | 0.9 | GO:0097489 | multivesicular body, internal vesicle lumen(GO:0097489) |
0.3 | 0.8 | GO:1990666 | PCSK9-LDLR complex(GO:1990666) |
0.2 | 1.2 | GO:0097513 | myosin II filament(GO:0097513) |
0.2 | 0.7 | GO:0071745 | IgA immunoglobulin complex(GO:0071745) IgA immunoglobulin complex, circulating(GO:0071746) monomeric IgA immunoglobulin complex(GO:0071748) polymeric IgA immunoglobulin complex(GO:0071749) secretory IgA immunoglobulin complex(GO:0071751) |
0.2 | 0.8 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.2 | 0.6 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.2 | 0.5 | GO:0036026 | protein C inhibitor-TMPRSS7 complex(GO:0036024) protein C inhibitor-TMPRSS11E complex(GO:0036025) protein C inhibitor-PLAT complex(GO:0036026) protein C inhibitor-PLAU complex(GO:0036027) protein C inhibitor-thrombin complex(GO:0036028) protein C inhibitor-KLK3 complex(GO:0036029) protein C inhibitor-plasma kallikrein complex(GO:0036030) serine protease inhibitor complex(GO:0097180) protein C inhibitor-coagulation factor V complex(GO:0097181) protein C inhibitor-coagulation factor Xa complex(GO:0097182) protein C inhibitor-coagulation factor XI complex(GO:0097183) |
0.2 | 0.7 | GO:0031436 | BRCA1-BARD1 complex(GO:0031436) |
0.2 | 3.2 | GO:0033391 | chromatoid body(GO:0033391) |
0.2 | 0.7 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
0.2 | 1.0 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.2 | 0.3 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.2 | 1.9 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.2 | 0.6 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.2 | 1.8 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.2 | 0.8 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.1 | 1.0 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.1 | 0.4 | GO:0071065 | dense core granule membrane(GO:0032127) alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex(GO:0071065) |
0.1 | 1.1 | GO:0035976 | AP1 complex(GO:0035976) |
0.1 | 1.2 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.1 | 0.7 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.1 | 0.5 | GO:0043293 | apoptosome(GO:0043293) |
0.1 | 0.4 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
0.1 | 0.6 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
0.1 | 0.8 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
0.1 | 0.5 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
0.1 | 0.4 | GO:0005607 | laminin-2 complex(GO:0005607) |
0.1 | 0.4 | GO:0005668 | RNA polymerase transcription factor SL1 complex(GO:0005668) |
0.1 | 0.5 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 1.1 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.1 | 0.6 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.1 | 3.7 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.1 | 0.4 | GO:0005818 | astral microtubule(GO:0000235) aster(GO:0005818) |
0.1 | 1.0 | GO:0000801 | central element(GO:0000801) |
0.1 | 0.3 | GO:0070762 | nuclear pore transmembrane ring(GO:0070762) |
0.1 | 0.7 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.1 | 1.0 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.1 | 0.5 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.1 | 0.5 | GO:0032010 | phagolysosome(GO:0032010) |
0.1 | 0.2 | GO:1990298 | mitotic checkpoint complex(GO:0033597) bub1-bub3 complex(GO:1990298) |
0.1 | 0.2 | GO:0000126 | transcription factor TFIIIB complex(GO:0000126) |
0.1 | 0.7 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.1 | 0.4 | GO:0032449 | CBM complex(GO:0032449) |
0.1 | 0.4 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.1 | 0.3 | GO:0042721 | mitochondrial inner membrane protein insertion complex(GO:0042721) |
0.1 | 0.5 | GO:0097013 | phagocytic vesicle lumen(GO:0097013) |
0.1 | 1.9 | GO:0042627 | chylomicron(GO:0042627) |
0.1 | 0.1 | GO:0030133 | transport vesicle(GO:0030133) |
0.1 | 0.2 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
0.1 | 0.6 | GO:0036128 | CatSper complex(GO:0036128) |
0.1 | 0.3 | GO:0031166 | integral component of vacuolar membrane(GO:0031166) |
0.1 | 0.9 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.1 | 0.5 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.1 | 2.8 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.1 | 0.3 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.1 | 1.1 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.1 | 0.9 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 1.4 | GO:0005861 | troponin complex(GO:0005861) |
0.1 | 0.3 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.1 | 0.2 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 0.2 | GO:0097444 | spine apparatus(GO:0097444) |
0.1 | 1.3 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.1 | 0.3 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 0.4 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.1 | 1.5 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 0.8 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.1 | 0.5 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 1.2 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.1 | 0.2 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
0.1 | 0.9 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
0.1 | 1.0 | GO:0036020 | endolysosome membrane(GO:0036020) |
0.1 | 1.1 | GO:0097342 | ripoptosome(GO:0097342) |
0.0 | 4.5 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.0 | 0.4 | GO:0071986 | Ragulator complex(GO:0071986) |
0.0 | 0.8 | GO:0031209 | SCAR complex(GO:0031209) |
0.0 | 0.4 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.0 | 0.1 | GO:1990745 | EARP complex(GO:1990745) |
0.0 | 0.3 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.0 | 1.1 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.2 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.0 | 0.1 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.0 | 0.7 | GO:0005883 | neurofilament(GO:0005883) |
0.0 | 0.7 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.0 | 0.4 | GO:0005638 | lamin filament(GO:0005638) |
0.0 | 1.5 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 1.0 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 0.2 | GO:0000799 | nuclear condensin complex(GO:0000799) |
0.0 | 0.5 | GO:0032797 | SMN complex(GO:0032797) |
0.0 | 0.1 | GO:0042022 | interleukin-12 receptor complex(GO:0042022) |
0.0 | 1.2 | GO:0033202 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
0.0 | 0.7 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 1.9 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 0.1 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.0 | 0.1 | GO:0048179 | activin receptor complex(GO:0048179) |
0.0 | 0.5 | GO:0000800 | lateral element(GO:0000800) |
0.0 | 1.3 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 0.3 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.0 | 0.8 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.0 | 0.2 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.0 | 0.2 | GO:0001520 | outer dense fiber(GO:0001520) |
0.0 | 0.8 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.0 | 0.1 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.0 | 0.2 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
0.0 | 0.4 | GO:0032426 | stereocilium tip(GO:0032426) |
0.0 | 0.9 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 0.1 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.0 | 1.3 | GO:0031904 | endosome lumen(GO:0031904) |
0.0 | 0.2 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.0 | 0.1 | GO:0031417 | NatC complex(GO:0031417) |
0.0 | 0.3 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.0 | 0.1 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
0.0 | 0.4 | GO:0005642 | annulate lamellae(GO:0005642) |
0.0 | 0.2 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.0 | 0.2 | GO:0036021 | endolysosome lumen(GO:0036021) |
0.0 | 0.2 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
0.0 | 0.5 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.0 | 0.2 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.0 | 0.6 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.0 | 0.6 | GO:0030056 | hemidesmosome(GO:0030056) |
0.0 | 0.4 | GO:0042555 | MCM complex(GO:0042555) |
0.0 | 0.2 | GO:0000796 | condensin complex(GO:0000796) |
0.0 | 0.6 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 0.7 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.0 | 0.1 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.0 | 0.2 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.0 | 1.8 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.3 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.0 | 0.8 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.0 | 0.4 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
0.0 | 0.5 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.0 | 0.8 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.0 | 0.7 | GO:0031105 | septin complex(GO:0031105) |
0.0 | 0.2 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.0 | 0.1 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.0 | 0.4 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.0 | 0.1 | GO:0097255 | R2TP complex(GO:0097255) |
0.0 | 0.6 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
0.0 | 0.4 | GO:0043034 | costamere(GO:0043034) |
0.0 | 1.2 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.7 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.0 | 0.1 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.0 | 0.1 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.0 | 0.2 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
0.0 | 2.8 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 0.3 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.0 | 0.5 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.0 | 0.3 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 0.5 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.0 | 0.1 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
0.0 | 0.6 | GO:0014704 | intercalated disc(GO:0014704) |
0.0 | 2.1 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.0 | 0.1 | GO:0036398 | TCR signalosome(GO:0036398) |
0.0 | 0.2 | GO:0070847 | core mediator complex(GO:0070847) |
0.0 | 0.7 | GO:0005685 | U1 snRNP(GO:0005685) |
0.0 | 0.8 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.0 | 0.2 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.0 | 2.4 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 0.1 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.0 | 0.4 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 0.2 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.0 | 1.4 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.0 | 0.3 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.0 | 0.7 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.0 | 0.5 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.0 | 1.7 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.0 | 0.1 | GO:0045298 | tubulin complex(GO:0045298) |
0.0 | 0.1 | GO:0001740 | Barr body(GO:0001740) |
0.0 | 0.2 | GO:0030424 | axon(GO:0030424) |
0.0 | 0.3 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 0.2 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.0 | 0.2 | GO:0005915 | zonula adherens(GO:0005915) |
0.0 | 0.9 | GO:0016460 | myosin II complex(GO:0016460) |
0.0 | 0.3 | GO:0045180 | basal cortex(GO:0045180) |
0.0 | 0.1 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.0 | 0.2 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.0 | 0.7 | GO:0031430 | M band(GO:0031430) |
0.0 | 0.6 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.0 | 0.1 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.0 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.0 | 0.6 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 0.0 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.0 | 0.4 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.0 | 0.1 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.0 | 0.2 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.0 | 0.2 | GO:0033268 | node of Ranvier(GO:0033268) |
0.0 | 0.2 | GO:0070081 | clathrin-sculpted monoamine transport vesicle(GO:0070081) clathrin-sculpted monoamine transport vesicle membrane(GO:0070083) |
0.0 | 0.1 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.0 | 3.2 | GO:0043197 | dendritic spine(GO:0043197) |
0.0 | 0.1 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.0 | 0.1 | GO:0051286 | cell tip(GO:0051286) |
0.0 | 0.5 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.0 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.0 | 0.3 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.5 | GO:0097228 | sperm principal piece(GO:0097228) |
0.0 | 0.2 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.0 | 0.1 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 1.2 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.4 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.0 | 0.4 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.0 | 0.1 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.0 | 0.2 | GO:0070652 | HAUS complex(GO:0070652) |
0.0 | 0.3 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.0 | 0.6 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 0.0 | GO:0097449 | astrocyte projection(GO:0097449) |
0.0 | 0.1 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.0 | 0.8 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.1 | GO:0019814 | immunoglobulin complex(GO:0019814) |
0.0 | 0.3 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.0 | 1.6 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.0 | 0.2 | GO:0031528 | microvillus membrane(GO:0031528) |
0.0 | 0.1 | GO:0070876 | SOSS complex(GO:0070876) |
0.0 | 0.1 | GO:0016013 | syntrophin complex(GO:0016013) |
0.0 | 0.1 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.0 | 0.1 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.0 | 1.0 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.0 | 0.1 | GO:0010369 | chromocenter(GO:0010369) |
0.0 | 0.1 | GO:0071547 | piP-body(GO:0071547) |
0.0 | 0.5 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.3 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.0 | 0.2 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.0 | 0.7 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.0 | 0.0 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.0 | 4.3 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.0 | 0.3 | GO:0005682 | U5 snRNP(GO:0005682) |
0.0 | 1.2 | GO:0030018 | Z disc(GO:0030018) |
0.0 | 0.4 | GO:0031201 | SNARE complex(GO:0031201) |
0.0 | 0.8 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 0.2 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 4.5 | GO:0045177 | apical part of cell(GO:0045177) |
0.0 | 1.1 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.0 | 0.7 | GO:0030016 | myofibril(GO:0030016) |
0.0 | 0.1 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 0.1 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.0 | 0.1 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.0 | 0.0 | GO:0016342 | catenin complex(GO:0016342) |
0.0 | 0.0 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.0 | 0.2 | GO:0035861 | site of double-strand break(GO:0035861) |
0.0 | 0.2 | GO:0035579 | specific granule membrane(GO:0035579) |
0.0 | 1.6 | GO:0005840 | ribosome(GO:0005840) |
0.0 | 0.4 | GO:0005905 | clathrin-coated pit(GO:0005905) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 2.4 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
0.7 | 2.1 | GO:0098809 | cystathionine beta-synthase activity(GO:0004122) oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) nitrite reductase (NO-forming) activity(GO:0050421) carbon monoxide binding(GO:0070025) nitrite reductase activity(GO:0098809) |
0.7 | 2.8 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.5 | 2.7 | GO:0008481 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
0.4 | 1.3 | GO:0015130 | mevalonate transmembrane transporter activity(GO:0015130) |
0.4 | 1.9 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.4 | 1.8 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
0.3 | 1.0 | GO:0005298 | proline:sodium symporter activity(GO:0005298) |
0.3 | 1.0 | GO:0001861 | complement component C4b receptor activity(GO:0001861) complement component C3b receptor activity(GO:0004877) |
0.3 | 1.9 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
0.3 | 1.0 | GO:0038131 | neuregulin receptor activity(GO:0038131) |
0.3 | 1.2 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) |
0.3 | 1.6 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
0.3 | 0.8 | GO:0004487 | methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.2 | 0.7 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
0.2 | 1.0 | GO:0086020 | gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling(GO:0086020) |
0.2 | 0.9 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.2 | 0.7 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
0.2 | 1.1 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.2 | 0.6 | GO:0032093 | SAM domain binding(GO:0032093) |
0.2 | 0.8 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.2 | 2.5 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.2 | 3.0 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.2 | 1.0 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.2 | 0.6 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.2 | 0.6 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.2 | 0.7 | GO:0016784 | 3-mercaptopyruvate sulfurtransferase activity(GO:0016784) |
0.2 | 0.9 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.2 | 0.5 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
0.2 | 1.6 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
0.2 | 2.8 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.2 | 0.7 | GO:0003867 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
0.2 | 0.8 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.2 | 1.0 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.2 | 0.7 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.2 | 0.5 | GO:0070052 | collagen V binding(GO:0070052) |
0.2 | 0.8 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.2 | 1.6 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.2 | 3.6 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.2 | 0.5 | GO:0003883 | CTP synthase activity(GO:0003883) |
0.2 | 0.8 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.2 | 0.5 | GO:0019981 | interleukin-6 receptor activity(GO:0004915) interleukin-6 binding(GO:0019981) |
0.2 | 0.5 | GO:0005330 | dopamine:sodium symporter activity(GO:0005330) |
0.1 | 1.2 | GO:0004064 | arylesterase activity(GO:0004064) |
0.1 | 0.4 | GO:0052856 | NADHX epimerase activity(GO:0052856) NADPHX epimerase activity(GO:0052857) |
0.1 | 0.4 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.1 | 0.9 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.1 | 0.6 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.8 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.1 | 0.4 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.1 | 0.4 | GO:0030984 | kininogen binding(GO:0030984) |
0.1 | 0.6 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.1 | 1.8 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
0.1 | 0.9 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.1 | 0.8 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.1 | 1.9 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 0.5 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.1 | 0.4 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.1 | 0.4 | GO:0004766 | spermidine synthase activity(GO:0004766) |
0.1 | 1.5 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.1 | 0.1 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.1 | 0.4 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.1 | 0.5 | GO:0010348 | lithium:proton antiporter activity(GO:0010348) |
0.1 | 0.5 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.1 | 0.7 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 0.4 | GO:0019107 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
0.1 | 0.5 | GO:0004802 | transketolase activity(GO:0004802) |
0.1 | 0.5 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
0.1 | 0.9 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.1 | 0.5 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.1 | 0.1 | GO:0043199 | sulfate binding(GO:0043199) |
0.1 | 0.4 | GO:0030107 | HLA-A specific inhibitory MHC class I receptor activity(GO:0030107) |
0.1 | 1.5 | GO:0031014 | troponin T binding(GO:0031014) |
0.1 | 0.3 | GO:0003980 | UDP-glucose:glycoprotein glucosyltransferase activity(GO:0003980) |
0.1 | 0.3 | GO:0008386 | cholesterol monooxygenase (side-chain-cleaving) activity(GO:0008386) |
0.1 | 0.3 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.1 | 1.1 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.1 | 0.8 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.1 | 0.2 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 0.5 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.1 | 0.4 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
0.1 | 0.3 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.1 | 0.5 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.1 | 0.9 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.1 | 1.0 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.1 | 0.3 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.1 | 1.4 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 1.2 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.1 | 0.7 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
0.1 | 0.6 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.1 | 0.6 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.1 | 0.5 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.1 | 0.5 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
0.1 | 2.0 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.1 | 0.4 | GO:0035473 | lipase binding(GO:0035473) |
0.1 | 0.4 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.1 | 0.1 | GO:0032089 | NACHT domain binding(GO:0032089) |
0.1 | 0.3 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.1 | 0.3 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
0.1 | 0.6 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.1 | 1.0 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 0.2 | GO:0030343 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.1 | 0.3 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.1 | 0.9 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.1 | 0.3 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
0.1 | 1.7 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 0.5 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
0.1 | 0.2 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.1 | 0.3 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
0.1 | 0.3 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.1 | 0.5 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.1 | 2.2 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 0.6 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 2.8 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 0.2 | GO:0001026 | TFIIIB-type transcription factor activity(GO:0001026) |
0.1 | 0.7 | GO:0008565 | protein transporter activity(GO:0008565) |
0.1 | 0.2 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
0.1 | 0.2 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
0.1 | 0.5 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 0.4 | GO:0070905 | serine binding(GO:0070905) |
0.1 | 1.0 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.1 | 0.4 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 1.2 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.1 | 0.2 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.1 | 0.8 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.1 | 0.6 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.1 | 1.1 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.1 | 0.2 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.1 | 1.1 | GO:0043225 | anion transmembrane-transporting ATPase activity(GO:0043225) |
0.1 | 0.9 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 0.6 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
0.1 | 0.8 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.1 | 0.2 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
0.1 | 0.5 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
0.1 | 0.3 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
0.1 | 0.3 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.1 | 0.8 | GO:0051378 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
0.1 | 0.3 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.1 | 0.7 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.1 | 1.0 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 0.8 | GO:0008199 | ferric iron binding(GO:0008199) |
0.1 | 0.4 | GO:0043515 | kinetochore binding(GO:0043515) |
0.1 | 0.1 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
0.1 | 0.2 | GO:0015403 | thiamine uptake transmembrane transporter activity(GO:0015403) uptake transmembrane transporter activity(GO:0015563) |
0.1 | 0.8 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.1 | 0.3 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.1 | 0.8 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 0.4 | GO:0023025 | MHC class Ib protein complex binding(GO:0023025) MHC class Ib protein binding, via antigen binding groove(GO:0023030) |
0.1 | 0.2 | GO:0004958 | prostaglandin F receptor activity(GO:0004958) |
0.1 | 0.2 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.1 | 0.2 | GO:0035501 | MH1 domain binding(GO:0035501) |
0.1 | 0.2 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.1 | 0.2 | GO:0000994 | RNA polymerase III core binding(GO:0000994) |
0.1 | 0.2 | GO:0051996 | farnesyl-diphosphate farnesyltransferase activity(GO:0004310) squalene synthase activity(GO:0051996) |
0.1 | 0.2 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
0.1 | 3.4 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 0.7 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.1 | 1.5 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 0.6 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.1 | 0.2 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.1 | 2.0 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.1 | 1.0 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.1 | 1.1 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.1 | 0.7 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.1 | 0.1 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.1 | 0.2 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.1 | 1.0 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.2 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.1 | 0.3 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 1.0 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.1 | 0.9 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 0.8 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.1 | 0.2 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.1 | 3.1 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.1 | 0.8 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 0.2 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.1 | 0.8 | GO:0032052 | bile acid binding(GO:0032052) |
0.1 | 0.2 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
0.1 | 0.5 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 0.2 | GO:0031716 | calcitonin receptor binding(GO:0031716) |
0.1 | 0.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.3 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.1 | 0.3 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 0.2 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
0.1 | 0.5 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.1 | 0.2 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.1 | 0.3 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.1 | 1.0 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.1 | 0.7 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.2 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.1 | 0.2 | GO:0032396 | inhibitory MHC class I receptor activity(GO:0032396) |
0.1 | 1.0 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.1 | 2.9 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 0.4 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.1 | 0.3 | GO:1903135 | cupric ion binding(GO:1903135) |
0.0 | 0.5 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.0 | 1.1 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.0 | 3.5 | GO:0019843 | rRNA binding(GO:0019843) |
0.0 | 0.4 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.0 | 1.2 | GO:0008483 | transaminase activity(GO:0008483) |
0.0 | 0.3 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.0 | 0.1 | GO:0004913 | interleukin-4 receptor activity(GO:0004913) interleukin-7 receptor activity(GO:0004917) |
0.0 | 0.6 | GO:0045159 | myosin II binding(GO:0045159) |
0.0 | 0.3 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.0 | 0.3 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.0 | 0.4 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.0 | 0.6 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.0 | 1.8 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.0 | 0.3 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.0 | 0.2 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
0.0 | 1.1 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.0 | 0.8 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.0 | 0.2 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.0 | 0.5 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.0 | 13.3 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.5 | GO:1901567 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.0 | 0.3 | GO:0071253 | connexin binding(GO:0071253) |
0.0 | 0.2 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.0 | 0.9 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 0.3 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.0 | 0.1 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.0 | 0.6 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.0 | 0.8 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.5 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.0 | 0.5 | GO:0031386 | protein tag(GO:0031386) |
0.0 | 0.1 | GO:0016517 | interleukin-12 receptor activity(GO:0016517) |
0.0 | 0.1 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.0 | 0.3 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.0 | 1.3 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.2 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.0 | 0.1 | GO:0019955 | cytokine binding(GO:0019955) |
0.0 | 0.7 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.0 | 0.1 | GO:0004347 | glucose-6-phosphate isomerase activity(GO:0004347) |
0.0 | 0.2 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
0.0 | 0.2 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.0 | 0.2 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.0 | 0.2 | GO:0008112 | nicotinamide N-methyltransferase activity(GO:0008112) pyridine N-methyltransferase activity(GO:0030760) |
0.0 | 0.4 | GO:0015266 | protein channel activity(GO:0015266) |
0.0 | 0.2 | GO:0051373 | FATZ binding(GO:0051373) |
0.0 | 0.2 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
0.0 | 0.2 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
0.0 | 0.2 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.0 | 0.1 | GO:0090631 | pre-miRNA transporter activity(GO:0090631) |
0.0 | 0.1 | GO:0046921 | glycoprotein 6-alpha-L-fucosyltransferase activity(GO:0008424) alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
0.0 | 0.2 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.0 | 0.1 | GO:0031780 | corticotropin hormone receptor binding(GO:0031780) type 5 melanocortin receptor binding(GO:0031783) |
0.0 | 1.0 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.0 | 1.3 | GO:0005504 | fatty acid binding(GO:0005504) |
0.0 | 0.1 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.0 | 0.0 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.0 | 0.1 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.0 | 0.1 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
0.0 | 0.5 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.0 | 0.2 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.0 | 0.1 | GO:0000035 | acyl binding(GO:0000035) |
0.0 | 0.1 | GO:0033149 | FFAT motif binding(GO:0033149) |
0.0 | 0.2 | GO:0052795 | exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.0 | 0.1 | GO:0070984 | SET domain binding(GO:0070984) |
0.0 | 0.2 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.5 | GO:0017166 | vinculin binding(GO:0017166) |
0.0 | 0.1 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.0 | 0.5 | GO:0031432 | titin binding(GO:0031432) |
0.0 | 0.2 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
0.0 | 0.8 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.3 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.0 | 0.2 | GO:0039552 | RIG-I binding(GO:0039552) |
0.0 | 0.3 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.0 | 0.2 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.0 | 0.1 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.0 | 0.2 | GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
0.0 | 0.3 | GO:0043426 | MRF binding(GO:0043426) |
0.0 | 2.8 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 2.5 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.4 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 0.6 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 3.8 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.2 | GO:0045174 | oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor(GO:0016672) glutathione dehydrogenase (ascorbate) activity(GO:0045174) methylarsonate reductase activity(GO:0050610) |
0.0 | 0.6 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.0 | 0.5 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 0.2 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.0 | 0.1 | GO:0043047 | single-stranded telomeric DNA binding(GO:0043047) G-rich strand telomeric DNA binding(GO:0098505) sequence-specific single stranded DNA binding(GO:0098847) |
0.0 | 0.3 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.0 | 0.3 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.0 | 0.1 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.0 | 0.2 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.0 | 0.3 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.0 | 0.3 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.0 | 1.7 | GO:0043022 | ribosome binding(GO:0043022) |
0.0 | 0.2 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.0 | 0.1 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.0 | 0.1 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.0 | 0.1 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
0.0 | 0.1 | GO:0047150 | betaine-homocysteine S-methyltransferase activity(GO:0047150) |
0.0 | 0.1 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 0.2 | GO:0033612 | receptor serine/threonine kinase binding(GO:0033612) |
0.0 | 0.2 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
0.0 | 0.8 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 0.1 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.0 | 0.7 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.0 | 0.1 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.0 | 0.5 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.1 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.0 | 0.3 | GO:0001046 | core promoter sequence-specific DNA binding(GO:0001046) |
0.0 | 0.1 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.0 | 1.7 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.1 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.0 | 0.1 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.0 | 0.1 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.0 | 0.3 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.0 | 0.1 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
0.0 | 0.6 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.8 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.0 | 2.9 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.0 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
0.0 | 0.3 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.2 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.0 | 0.2 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.0 | 0.1 | GO:0017018 | myosin phosphatase activity(GO:0017018) |
0.0 | 0.1 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.0 | 0.3 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.0 | 0.4 | GO:0035064 | methylated histone binding(GO:0035064) |
0.0 | 0.2 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.0 | 1.1 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.0 | 0.4 | GO:0001164 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.0 | 0.1 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.0 | 0.2 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.0 | 0.1 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.0 | 0.1 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.0 | 0.3 | GO:0031996 | thioesterase binding(GO:0031996) |
0.0 | 0.1 | GO:0004603 | phenylethanolamine N-methyltransferase activity(GO:0004603) |
0.0 | 0.6 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
0.0 | 0.2 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.0 | 0.4 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.0 | 0.9 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.0 | 0.2 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.1 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.0 | 0.1 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.0 | 0.1 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.0 | 0.1 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.0 | 0.2 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.0 | 0.5 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.2 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
0.0 | 0.0 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.0 | 0.1 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.0 | 0.5 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.4 | GO:0043495 | protein anchor(GO:0043495) |
0.0 | 0.3 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.0 | 0.4 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.0 | 0.5 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.0 | 0.2 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 0.2 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 0.2 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.0 | 0.7 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.0 | 0.1 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
0.0 | 0.6 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.0 | 0.1 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.0 | 0.1 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 0.3 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.0 | 0.2 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.0 | 0.1 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.0 | 0.2 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.0 | 0.1 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.0 | 0.2 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.0 | 0.7 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.0 | 0.0 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.0 | 0.1 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
0.0 | 0.8 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.0 | 0.3 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.0 | 0.1 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.0 | 0.1 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.0 | 0.0 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 0.1 | GO:0048495 | Roundabout binding(GO:0048495) |
0.0 | 0.1 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.0 | 0.2 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.0 | 0.2 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 0.2 | GO:0009374 | biotin binding(GO:0009374) |
0.0 | 0.1 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.0 | 0.5 | GO:0030552 | cAMP binding(GO:0030552) |
0.0 | 0.3 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.0 | 1.2 | GO:0001618 | virus receptor activity(GO:0001618) |
0.0 | 1.6 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.0 | 0.2 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.1 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 0.2 | GO:0005113 | patched binding(GO:0005113) |
0.0 | 0.9 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 0.1 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.0 | 0.5 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.0 | 0.0 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.0 | 0.1 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.0 | 0.0 | GO:0001596 | angiotensin type I receptor activity(GO:0001596) |
0.0 | 0.5 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.3 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 0.2 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.2 | GO:0032183 | SUMO binding(GO:0032183) |
0.0 | 0.6 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.0 | 0.1 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.0 | 0.2 | GO:0070403 | NAD+ binding(GO:0070403) |
0.0 | 0.5 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.0 | 0.2 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.0 | 4.2 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 0.4 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
0.0 | 0.0 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.0 | 0.2 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.0 | 0.7 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.0 | 0.7 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.0 | 0.0 | GO:0071207 | histone pre-mRNA stem-loop binding(GO:0071207) |
0.0 | 1.0 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.6 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.0 | 0.0 | GO:0005534 | galactose binding(GO:0005534) |
0.0 | 0.3 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.0 | 0.0 | GO:0004817 | cysteine-tRNA ligase activity(GO:0004817) |
0.0 | 0.3 | GO:0000217 | DNA secondary structure binding(GO:0000217) |
0.0 | 0.5 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.0 | 0.4 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.0 | 0.9 | GO:0019213 | deacetylase activity(GO:0019213) |
0.0 | 0.1 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.0 | 0.0 | GO:0004878 | complement component C5a receptor activity(GO:0004878) |
0.0 | 0.1 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.0 | 0.2 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.0 | 0.1 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.1 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.0 | 0.0 | GO:0004822 | isoleucine-tRNA ligase activity(GO:0004822) |
0.0 | 0.4 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.0 | 0.1 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.0 | 0.5 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.0 | 0.1 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.0 | 0.3 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.0 | 0.1 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.0 | 0.3 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 0.0 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.0 | 0.0 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
0.0 | 0.0 | GO:0004960 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
0.0 | 0.2 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 0.1 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.0 | 0.4 | GO:0045182 | translation regulator activity(GO:0045182) |
0.0 | 0.1 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
0.0 | 0.0 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.0 | 0.1 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 5.3 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 9.1 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 3.7 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 3.2 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.1 | 3.7 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 1.3 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 1.5 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 1.8 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 2.5 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 0.2 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 1.5 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 2.6 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.1 | 0.2 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 4.2 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.1 | 3.0 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 2.2 | PID IFNG PATHWAY | IFN-gamma pathway |
0.0 | 1.2 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 2.0 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 0.1 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.0 | 3.2 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 1.7 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 1.0 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 0.1 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 0.4 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 2.0 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 1.1 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.0 | 2.8 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.0 | 0.6 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 1.1 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 1.8 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 1.6 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 0.5 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.5 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 0.2 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 0.4 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 8.1 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.9 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 0.7 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 0.1 | PID EPO PATHWAY | EPO signaling pathway |
0.0 | 0.0 | ST GAQ PATHWAY | G alpha q Pathway |
0.0 | 1.2 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 1.3 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.7 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 0.2 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 0.2 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 1.0 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 0.4 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 0.6 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 0.8 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 0.5 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.0 | 0.4 | PID IGF1 PATHWAY | IGF1 pathway |
0.0 | 0.4 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.3 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.6 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.3 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 5.8 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.6 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 0.3 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 0.6 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 0.5 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 0.7 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.0 | 0.4 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 0.1 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 0.6 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.4 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 0.2 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.2 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.1 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.0 | 0.1 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 0.5 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.2 | 0.6 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.2 | 2.9 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.1 | 3.0 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 0.1 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.1 | 2.8 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 4.6 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 2.1 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.1 | 1.1 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 2.2 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.1 | 1.4 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.1 | 1.4 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 5.7 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.1 | 1.9 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.1 | 3.2 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 2.6 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 1.7 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 2.1 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 3.5 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.1 | 1.8 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 0.9 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.1 | 1.1 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.1 | 2.6 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.1 | 2.0 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.1 | 0.6 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.1 | 0.5 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 1.1 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 7.1 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.1 | 0.5 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.1 | 0.2 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.1 | 0.7 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.0 | 3.0 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.0 | 1.1 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.0 | 0.3 | REACTOME PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | Genes involved in Processive synthesis on the lagging strand |
0.0 | 0.2 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.0 | 0.6 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.0 | 1.0 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 0.6 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.0 | 0.5 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 1.1 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 1.0 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 1.1 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 0.7 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 0.5 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.0 | 1.8 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.0 | 0.8 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.0 | 0.8 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 0.7 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.0 | 0.9 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 0.6 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.0 | 2.0 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.0 | 1.1 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.0 | 1.0 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.4 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 1.1 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.8 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 1.0 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.6 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.0 | 1.2 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.0 | 1.1 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.0 | 0.3 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.0 | 0.6 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.0 | 0.6 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 3.1 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.0 | 0.4 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.0 | 0.4 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 0.9 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.0 | 0.4 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 0.9 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.0 | 0.2 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.0 | 0.3 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 1.1 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.4 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 1.6 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 1.7 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 4.4 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.0 | 0.8 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.6 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.8 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.0 | 2.0 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 0.3 | REACTOME GLOBAL GENOMIC NER GG NER | Genes involved in Global Genomic NER (GG-NER) |
0.0 | 0.2 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.1 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 0.5 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.0 | 0.2 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.0 | 0.2 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.1 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.0 | 0.4 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 1.7 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.0 | 0.2 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.0 | 0.3 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.0 | 0.4 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 1.5 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.3 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 0.3 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.2 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.0 | 0.7 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.2 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.3 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.0 | 0.4 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.0 | 0.1 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.0 | 0.4 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.0 | 0.4 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.0 | 0.6 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 0.2 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.0 | 1.0 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.0 | 0.4 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 0.2 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.9 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 0.3 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.0 | 0.4 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 0.3 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.0 | 0.3 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.0 | 0.5 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 0.1 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.0 | 0.1 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.0 | 0.0 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.0 | 0.3 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.3 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.0 | 0.3 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.7 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 0.2 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.0 | 0.3 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.1 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.0 | 0.1 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.0 | 1.3 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 1.6 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.2 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.0 | 0.1 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.0 | 0.3 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 0.1 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.0 | 0.3 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.1 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.2 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.0 | 0.2 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 0.6 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |